CHEMOTHERAPY VS IMMUNOTHERAPY AS NEOADJUVANT THERAPIES IN CISPLATIN-ELIGIBLE PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Nocera, Luigi
Bandini, Marco
Basile, Giuseppe
Moschini, Marco
Naidu, Shreyas
Rose, Kyle
Li, Roger
Spiess, Philippe
Necchi, Andrea
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD44-06
引用
下载
收藏
页码：E1126 / E1127
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer
    Stevenson, Scott M.
    Danzig, Matthew R.
    Ghandour, Rashed A.
    Deibert, Christopher M.
    Decastro, G. Joel
    Benson, Mitchell C.
    McKiernan, James M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1172 - 1177
  • [42] Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer
    Michel, C.
    Vordos, D.
    Dumont, C.
    Basset, V
    Meyer, F.
    Gaudez, F.
    Meria, P.
    Cortesse, A.
    Mongiat-Artus, P.
    de la Taille, A.
    Culine, S.
    Desgrandchamps, F.
    Masson-Lecomte, A.
    [J]. PROGRES EN UROLOGIE, 2018, 28 (10): : 495 - 501
  • [43] EFFICIENT DELIVERY OF RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER: A MULTIDISCIPLINARY APPROACH
    Alva, Ajjai
    Tallman, Christopher
    He, Chang
    Hussain, Maha
    Hafez, Khaled
    Montie, James
    Smith, David
    Weizer, Alon
    Wood, David
    Lee, Cheryl
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E568 - E568
  • [44] A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder cancer (MIBC).
    Sonpavde, Guru
    Necchi, Andrea
    Gupta, Shilpa
    Steinberg, Gary D.
    Gschwend, Juergen E.
    Van der Heijden, Michiel Simon
    Garzon, Nathalie
    Elegbe, Ayanbola
    Raybold, Bradley
    Liaw, Danny
    Rutstein, Mark
    Galsky, Matt D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Outcome of patients undergoing radical cystectomy for invasive bladder cancer
    Gschwend, JE
    [J]. CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 106 - 117
  • [46] Systemic Treatment for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Laparoscopic Radical Cystectomy
    Barret, Eric
    Sanchez-Salas, Rafael
    Vallancien, Guy
    [J]. INTERNATIONAL BRAZ J UROL, 2008, 34 (04): : 513 - 515
  • [47] A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer - Comment
    Scher, HI
    [J]. JOURNAL OF UROLOGY, 1996, 155 (02): : 499 - 500
  • [48] Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Study of Renal Impairment in Relation to Potential Thromboprophylaxis
    Rydell, Harriet
    Ericson, Anna
    Eriksson, Victoria
    Johansson, Markus
    Svensson, Johan
    Banday, Viqar
    Sherif, Amir
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
  • [49] Characteristics, treatment patterns, and clinical outcomes of patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer in the real world.
    Law, Jeanna Wallenta
    Turzhitsky, Vladimir
    Li, Haojie
    Izano, Monika A.
    Kataria, Ritesh S.
    Burcu, Mehmet
    Marks-Anglin, Arielle
    Min, Jae
    Kao, Yu-Han
    Sweetnam, Connor
    Kane, Kaitlyn
    Berry, Anna B.
    Walters, Sheetal
    Porten, Sima P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 552 - 552
  • [50] Neoadjuvant pembrolizumab for cisplatin-ineligible muscle-invasive bladder cancer prior to radical cystectomy.
    Rose, Kyle M.
    Bandini, Marco
    Huelster, Heather L.
    Basile, Giuseppe
    Naidu, Shreyas U.
    Spiess, Philippe E.
    Necchi, Andrea
    Li, Roger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345